These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 10908112

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intermediates of rifamycin polyketide synthase produced by an Amycolatopsis mediterranei mutant with inactivated rifF gene.
    Stratmann A, Toupet C, Schilling W, Traber R, Oberer L, Schupp T.
    Microbiology (Reading); 1999 Dec; 145 ( Pt 12)():3365-3375. PubMed ID: 10627035
    [Abstract] [Full Text] [Related]

  • 4. Cloning and partial characterization of the putative rifamycin biosynthetic gene cluster from the actinomycete Amycolatopsis mediterranei DSM 46095.
    Kaur H, Cortes J, Leadlay P, Lal R.
    Microbiol Res; 2001 Dec; 156(3):239-46. PubMed ID: 11716212
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Isolation and characterization of 27-O-demethylrifamycin SV methyltransferase provides new insights into the post-PKS modification steps during the biosynthesis of the antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.
    Xu J, Mahmud T, Floss HG.
    Arch Biochem Biophys; 2003 Mar 15; 411(2):277-88. PubMed ID: 12623077
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Differential mass spectrometry-based proteome analyses unveil major regulatory hubs in rifamycin B production in Amycolatopsis mediterranei.
    Singhvi N, Singh P, Prakash O, Gupta V, Lal S, Bechthold A, Singh Y, Singh RK, Lal R.
    J Proteomics; 2021 May 15; 239():104168. PubMed ID: 33662614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A homologue of the Mycobacterium tuberculosis PapA5 protein, rif-orf20, is an acetyltransferase involved in the biosynthesis of antitubercular drug rifamycin B by Amycolatopsis mediterranei S699.
    Xiong Y, Wu X, Mahmud T.
    Chembiochem; 2005 May 15; 6(5):834-7. PubMed ID: 15791687
    [No Abstract] [Full Text] [Related]

  • 16. Rifamycin W Analogues from Amycolatopsis mediterranei S699 Δrif-orf5 Strain.
    Shi Y, Ye F, Song Y, Zhang X, Lu C, Shen Y.
    Biomolecules; 2021 Jun 22; 11(7):. PubMed ID: 34206314
    [Abstract] [Full Text] [Related]

  • 17. RifZ (AMED_0655) Is a Pathway-Specific Regulator for Rifamycin Biosynthesis in Amycolatopsis mediterranei.
    Li C, Liu X, Lei C, Yan H, Shao Z, Wang Y, Zhao G, Wang J, Ding X.
    Appl Environ Microbiol; 2017 Apr 15; 83(8):. PubMed ID: 28159794
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibiotic biosynthesis: from natural to unnatural compounds.
    Floss HG.
    J Ind Microbiol Biotechnol; 2001 Sep 15; 27(3):183-94. PubMed ID: 11780790
    [Abstract] [Full Text] [Related]

  • 20. New insights into rifamycin B biosynthesis: isolation of proansamycin B and 34a-deoxy-rifamycin W as early macrocyclic intermediates indicating two separated biosynthetic pathways.
    Stratmann A, Schupp T, Toupet C, Schilling W, Oberer L, Traber R.
    J Antibiot (Tokyo); 2002 Apr 15; 55(4):396-406. PubMed ID: 12061548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.